GSK Settlement: Changing The Way Drug Cos. Do Business?
July 12, 2012, 1:52 PM EDT
Law360, New York (July 12, 2012, 1:52 PM EDT) -- On July 2, 2012, the U.S. Department of Justice announced the largest health care fraud settlement in U.S. history: GlaxoSmithKline LLC will pay $3 billion to resolve criminal and civil allegations of unlawfully promoting prescription drugs, failing to report safety data and engaging in allegedly false price reporting practices. This resolution includes a criminal fine and forfeiture totaling $1 billion and $2 billion in civil payments.
Historically Severe Criminal and Civil Fines
Under the Food, Drug and Cosmetic Act (“FDCA”), GSK may promote its prescription drugs...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.